363 related articles for article (PubMed ID: 11218067)
1. 5HT4(a) and 5-HT4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle.
Bach T; Syversveen T; Kvingedal AM; Krobert KA; Brattelid T; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):146-60. PubMed ID: 11218067
[TBL] [Abstract][Full Text] [Related]
2. Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i).
Brattelid T; Kvingedal AM; Krobert KA; Andressen KW; Bach T; Hystad ME; Kaumann AJ; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):616-28. PubMed ID: 15118808
[TBL] [Abstract][Full Text] [Related]
3. Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants.
Krobert KA; Brattelid T; Levy FO; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):473-9. PubMed ID: 16012870
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium.
Blondel O; Vandecasteele G; Gastineau M; Leclerc S; Dahmoune Y; Langlois M; Fischmeister R
FEBS Lett; 1997 Aug; 412(3):465-74. PubMed ID: 9276448
[TBL] [Abstract][Full Text] [Related]
5. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution.
Krobert KA; Bach T; Syversveen T; Kvingedal AM; Levy FO
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):620-32. PubMed ID: 11414657
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
Blondel O; Gastineau M; Dahmoune Y; Langlois M; Fischmeister R
J Neurochem; 1998 Jun; 70(6):2252-61. PubMed ID: 9603189
[TBL] [Abstract][Full Text] [Related]
7. A 5-HT4-like receptor in human right atrium.
Kaumann AJ; Sanders L; Brown AM; Murray KJ; Brown MJ
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):150-9. PubMed ID: 1658664
[TBL] [Abstract][Full Text] [Related]
8. Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.
Mialet J; Berque-Bestel I; Eftekhari P; Gastineau M; Giner M; Dahmoune Y; Donzeau-Gouge P; Hoebeke J; Langlois M; Sicsic S; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Feb; 129(4):771-81. PubMed ID: 10683202
[TBL] [Abstract][Full Text] [Related]
9. The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.
Gerald C; Adham N; Kao HT; Olsen MA; Laz TM; Schechter LE; Bard JA; Vaysse PJ; Hartig PR; Branchek TA
EMBO J; 1995 Jun; 14(12):2806-15. PubMed ID: 7796807
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells.
Mialet J; Berque-Bestel I; Sicsic S; Langlois M; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2000 Oct; 131(4):827-35. PubMed ID: 11030734
[TBL] [Abstract][Full Text] [Related]
11. [3H]5-hydroxytryptamine labels the agonist high affinity state of the cloned rat 5-HT4 receptor.
Adham N; Gerald C; Schechter L; Vaysse P; Weinshank R; Branchek T
Eur J Pharmacol; 1996 May; 304(1-3):231-5. PubMed ID: 8813606
[TBL] [Abstract][Full Text] [Related]
12. Investigations into the binding affinities of different human 5-HT4 receptor splice variants.
Irving HR; Tochon-Danguy N; Chinkwo KA; Li JG; Grabbe C; Shapiro M; Pouton CW; Coupar IM
Pharmacology; 2010; 85(4):224-33. PubMed ID: 20299822
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium.
Medhurst AD; Kaumann AJ
Br J Pharmacol; 1993 Nov; 110(3):1023-30. PubMed ID: 8298790
[TBL] [Abstract][Full Text] [Related]
14. [3H]RS 57639, a high affinity, selective 5-HT4 receptor partial agonist, specifically labels guinea-pig striatal and rat cloned (5-HT4S and 5-HT4L) receptors.
Bonhaus DW; Berger J; Adham N; Branchek TA; Hsu SA; Loury DN; Leung E; Wong EH; Clark RD; Eglen RM
Neuropharmacology; 1997; 36(4-5):671-9. PubMed ID: 9225293
[TBL] [Abstract][Full Text] [Related]
15. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
Krobert KA; Andressen KW; Levy FO
Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
[TBL] [Abstract][Full Text] [Related]
16. Cloning and expression of a human serotonin 5-HT4 receptor cDNA.
Van den Wyngaert I; Gommeren W; Verhasselt P; Jurzak M; Leysen J; Luyten W; Bender E
J Neurochem; 1997 Nov; 69(5):1810-9. PubMed ID: 9349523
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptors.
Claeysen S; Sebben M; Bécamel C; Eglen RM; Clark RD; Bockaert J; Dumuis A
Mol Pharmacol; 2000 Jul; 58(1):136-44. PubMed ID: 10860935
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
[TBL] [Abstract][Full Text] [Related]
19. Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain.
Dumuis A; Sebben M; Monferini E; Nicola M; Turconi M; Ladinsky H; Bockaert J
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):245-51. PubMed ID: 1650917
[TBL] [Abstract][Full Text] [Related]
20. Identification of the adenylyl cyclase-activating 5-hydroxytryptamine receptor subtypes expressed in the rat submandibular gland.
Bourdon DM; Camden JM; Landon LA; Levy FO; Turner JT
Br J Pharmacol; 2000 May; 130(1):104-8. PubMed ID: 10781004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
